<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2020-11-132-137</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-5762</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЭНДОКРИНОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ENDOCRINOLOGY</subject></subj-group></article-categories><title-group><article-title>Возможности мобильного здравоохранения для лечения диабета в условиях пандемии COVID-19</article-title><trans-title-group xml:lang="en"><trans-title>Capabilities of mobile health to treat diabetes in the conditions of the COVID-19 pandemic</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8436-9029</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Болотская</surname><given-names>Л. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Bolotskaya</surname><given-names>L. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Болотская Любовь Леонидовна, к.м.н., ведущий научный сотрудник отделения Федерального регистра диабета РФ, врач-эндокринолог высшей категории лечебно-реабилитационного отделения </p><p>117036, Москва, ул. Дмитрия Ульянова, д. 11</p></bio><bio xml:lang="en"><p>Lubov L. Bolotskaya, Cand. of Sci. (Med.), Leading Researcher of the Department of the Federal Diabetes Registry of the Russian Federation, Board-Certified Endocrinologist of the Department of Treatment and Rehabilitation </p><p>11, Dmitry Ulyanov St., Moscow, 117036</p></bio><email xlink:type="simple">BolotskayaLiubov@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр эндокринологии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center for Endocrinology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>06</day><month>08</month><year>2020</year></pub-date><volume>0</volume><issue>11</issue><fpage>132</fpage><lpage>137</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Болотская Л.Л., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Болотская Л.Л.</copyright-holder><copyright-holder xml:lang="en">Bolotskaya L.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/5762">https://www.med-sovet.pro/jour/article/view/5762</self-uri><abstract><p>Пациенты с сахарным диабетом (СД1, СД2) относятся к высокой группе риска при изменении эпидемиологической ситуации во время сезонных заболеваний (грипп, ОРВИ), которые в основном наблюдаются в осенне-зимний период. В связи с пандемией СOVID-19 эти пациенты оказались наиболее уязвимы, так как период самоизоляции ограничил возможность динамического наблюдения пациента врачами общей практики, эндокринологом, офтальмологом, специалистом кабинета «диабетическая стопа», затруднил своевременную выписку рецептов на льготные сахароснижающие препараты и решение вопросов плановой госпитализации в специализированные медицинские учреждения. Пациенты, которые по ряду причин и так обладают низкой комплаентностью по отношению к своему хроническому заболеванию, были лишены возможности обсудить с врачом коррекцию сахароснижающей терапии в короткий период времени. Любое ограничение доступности консультации врача серьезно влияет на психоэмоциональное состояние пациентов c различными типами СД, что часто приводит к повышению показателей глюкозы крови выше целевого уровня (5,5–6,5 ммоль/л) и, как следствие, к развитию острых и прогрессированию хронических осложнений диабета. Инструментом для пациентов во время самоизоляции могут служить современные технологии в виде мобильного руководства по управлению диабетом. Помимо доступной связи с врачом, руководство даст пациенту возможность самостоятельно принимать решение и быть вовлеченным в процесс лечения. Таким образом, возникает необходимость внедрения нового формата медицинских консультаций «пациент – врач» с использованием инновационных технологий. В статье представлен опыт оказания консультативной помощи для пациентов с диабетом в формате мобильного здравоохранения дистанционно, с использованием мобильного приложения Contour Diabetes («Контур Диабитис») к глюкометру Contour™ Plus Оne («Контур Плюс Уан»).</p></abstract><trans-abstract xml:lang="en"><p>Patients with diabetes mellitus (DM 1.2) are at high risk for changing the epidemiological situation during seasonal diseases (influenza, SARS), which mainly occur in the autumn-winter period. Under the current conditions in connection with the pandemic – СOVID-19, these patients turned out to be the most vulnerable, since the “isolation period” limits the possibility of dynamic observation of the patient by a general practitioner, an ophthalmologist, a specialist in the diabetic foot cabinet, and timely prescribing for preferential sugar-lowering drugs and resolving issues of planned hospitalization in specialized medical institutions. Patients who, for a numerous reasons have already have a low level of compliance with their chronic disease, were un-able to consult with a doctor on the topic of correction of sugar-lowering therapy in a short period of time. Any restriction on doctor’s consultation seriously affects the psycho-emotional state of patients with various types of diabetes, which often leads to an increase in blood glucose levels above the target level (5.5–6.5 mmol/L) and, as a result, leads to the development of acute and the progression of chronic diabetes complications. Modern technology in the form of a mobile diabetes management guide can serve as a helpful tool for patients during the “self-isolation”. In addition to the established communication with the doctor, the instructions will give patient the opportunity to make their own decisions and be involved in the treatment process. New time dictates the needs introduction of a new medical format consultation “doctor-patient”. The article presents the experience of providing counseling for patients with diabetes in the “mobile health care” format using the Contour Diabetes mobile app for the Contour™ Plus One meter (Contour Plus One).</p></trans-abstract><kwd-group xml:lang="ru"><kwd>диабет</kwd><kwd>пандемия COVID-19</kwd><kwd>глюкоза крови</kwd><kwd>мобильное приложение</kwd><kwd>глюкометр</kwd></kwd-group><kwd-group xml:lang="en"><kwd>diabetes</kwd><kwd>pandemic COVID-19</kwd><kwd>blood glucose</kwd><kwd>mobile app</kwd><kwd>blood glucose meter</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Garg S.K., Rodbard D., Hirsch I., Forlenza G.P. Managing New-Onset Type 1 Diabetes During the COVID-19 Pandemic: Challenges and Opportunities. Diabetes Technol Ther. 2020;22(6):431–439. doi: 10.1089/dia.2020.0161.</mixed-citation><mixed-citation xml:lang="en">Garg S.K., Rodbard D., Hirsch I., Forlenza G.P. Managing New-Onset Type 1 Diabetes During the COVID-19 Pandemic: Challenges and Opportunities. Diabetes Technol Ther. 2020;22(6):431–439. doi: 10.1089/dia.2020.0161.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">McDonnell M.E. Telemedicine in complex diabetes management. Curr Diab Rep. 2018;18(7):42. doi: 10.1007/s11892-018-1015-3.</mixed-citation><mixed-citation xml:lang="en">McDonnell M.E. Telemedicine in complex diabetes management. Curr Diab Rep. 2018;18(7):42. doi: 10.1007/s11892-018-1015-3.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Silver M.P. Patient Perspectives on Online Health Information and Communication With Doctors: A Qualitative Study of Patients 50 Years Old and Over. J Med Internet Res. 2015;17(1):e19. doi: 10.2196/jmir.3588.</mixed-citation><mixed-citation xml:lang="en">Silver M.P. Patient Perspectives on Online Health Information and Communication With Doctors: A Qualitative Study of Patients 50 Years Old and Over. J Med Internet Res. 2015;17(1):e19. doi: 10.2196/jmir.3588.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Quinn C.C., Clough S.S., Minor J.M., Lender D., Okafor M.C., Gruber-Baldini A. WellDoc mobile diabetes management randomized controlled trial: change in clinical and behavioral outcomes and patient and physician satisfaction. Diabetes Technol Ther. 2008;10(3):160–168. doi: 10.1089/dia.2008.0283.</mixed-citation><mixed-citation xml:lang="en">Quinn C.C., Clough S.S., Minor J.M., Lender D., Okafor M.C., Gruber-Baldini A. WellDoc mobile diabetes management randomized controlled trial: change in clinical and behavioral outcomes and patient and physician satisfaction. Diabetes Technol Ther. 2008;10(3):160–168. doi: 10.1089/dia.2008.0283.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ryu S. New Horizons for Health through Mobile Technologies: Based on the Findings of the Second Global Survey on eHealth (Global Observatory for eHealth Series, Volume 3). Healthc Inform Res. 2012;18(3):231–233. doi: 10.4258/hir.2012.18.3.231.</mixed-citation><mixed-citation xml:lang="en">Ryu S. New Horizons for Health through Mobile Technologies: Based on the Findings of the Second Global Survey on eHealth (Global Observatory for eHealth Series, Volume 3). Healthc Inform Res. 2012;18(3):231–233. doi: 10.4258/hir.2012.18.3.231.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Xesfingi S., Vozikis A. Health Literacy: In the Quest of the Contributing Factors. Interact J Med Res. 2016;5(2):e16. doi: 10.2196/ijmr.4749.</mixed-citation><mixed-citation xml:lang="en">Xesfingi S., Vozikis A. Health Literacy: In the Quest of the Contributing Factors. Interact J Med Res. 2016;5(2):e16. doi: 10.2196/ijmr.4749.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Richardson J., Pardo S., Shaginian R. The Patient Characteristics Of Contour Diabetes App Users Worldwide. Diabetes. 2020;69(1). doi: 10.2337/db20-2181-PUB.</mixed-citation><mixed-citation xml:lang="en">Richardson J., Pardo S., Shaginian R. The Patient Characteristics Of Contour Diabetes App Users Worldwide. Diabetes. 2020;69(1). doi: 10.2337/db20-2181-PUB.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang H.J., Stryer D., Friedman B., Andrews R. Multiple hospitalizations for patients with diabetes. Diabetes Care. 2003;26(6):1421–1426. doi: 10.2337/diacare.26.5.1421.</mixed-citation><mixed-citation xml:lang="en">Jiang H.J., Stryer D., Friedman B., Andrews R. Multiple hospitalizations for patients with diabetes. Diabetes Care. 2003;26(6):1421–1426. doi: 10.2337/diacare.26.5.1421.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Dunne N., Viggiani M.T., Pardo S., Robinson C., Parkes J.L. Accuracy Evaluation of CONTOUR(®)PLUS Compared With Four Blood Glucose Monitoring Systems. Diabetes Ther. 2015;6:377–388. doi: 10.1007/s13300-015-0121-3.</mixed-citation><mixed-citation xml:lang="en">Dunne N., Viggiani M.T., Pardo S., Robinson C., Parkes J.L. Accuracy Evaluation of CONTOUR(®)PLUS Compared With Four Blood Glucose Monitoring Systems. Diabetes Ther. 2015;6:377–388. doi: 10.1007/s13300-015-0121-3.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bailey T.S., Wallace J.F., Pardo S., Warchal-Windham M.E., Harrison B., Morin R., Christiansen M. Accuracy and User Performance Evaluation of a New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device. J Diabetes Sci Technol. 2017;11(4):736–743. doi: 10.1177/1932296816680829.</mixed-citation><mixed-citation xml:lang="en">Bailey T.S., Wallace J.F., Pardo S., Warchal-Windham M.E., Harrison B., Morin R., Christiansen M. Accuracy and User Performance Evaluation of a New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device. J Diabetes Sci Technol. 2017;11(4):736–743. doi: 10.1177/1932296816680829.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">American Diabetes Association. Economic Costs of Diabetes in the U.S. in 2017. Diabetes Care. 2018;41(5):917–928. doi: 10.2337/dci18-0007.</mixed-citation><mixed-citation xml:lang="en">American Diabetes Association. Economic Costs of Diabetes in the U.S. in 2017. Diabetes Care. 2018;41(5):917–928. doi: 10.2337/dci18-0007.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Fleming G.A., Petrie J.R., Bergenstal R.M., Holl R.W., Peters A.L., Heinemann L. Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group. Diabetologia. 2020;63(2):229-241. doi: 10.1007/s00125-019-05034-1.</mixed-citation><mixed-citation xml:lang="en">Fleming G.A., Petrie J.R., Bergenstal R.M., Holl R.W., Peters A.L., Heinemann L. Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group. Diabetologia. 2020;63(2):229-241. doi: 10.1007/s00125-019-05034-1.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Zimmer-Galler I.E., Kimura A.E., Gupta S. Diabetic retinopathy screening and the use of telemedicine. Curr Opin Ophthal. 2015;26(3):167–172. doi: 10.1097/ICU.0000000000000142.</mixed-citation><mixed-citation xml:lang="en">Zimmer-Galler I.E., Kimura A.E., Gupta S. Diabetic retinopathy screening and the use of telemedicine. Curr Opin Ophthal. 2015;26(3):167–172. doi: 10.1097/ICU.0000000000000142.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Xie B. Effects of an eHealth literacy intervention for older adults. J Med Internet Res. 2011;13(4):e90. doi: 10.2196/jmir.1880.</mixed-citation><mixed-citation xml:lang="en">Xie B. Effects of an eHealth literacy intervention for older adults. J Med Internet Res. 2011;13(4):e90. doi: 10.2196/jmir.1880.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
